PX
Paxman AB (publ)
PXMBF · OTC
$3.50 +0.00% (+$0.00)
Market Cap 641.0M kr
P/E Ratio -
Div. Yield -
ROE 1.22%
Bulios Fair Price
$1.82
48.0% downside
Current Price
$3.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PXMBF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
67 /100
Cheap EV/EBITDA 14.52x
P/S 1.76x
P/B 1.55x
Growth
100 /100
Growing Rev. growth 25.87%
Book val. growth 52.39%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 32.04%
Net margin 1.39%
FCF margin 6.60%
Quality
9 /100
Poor ROIC 1.21%
ROE 1.22%
Asset turnover 0.75x
Debt
87 /100
Low Debt/Equity 0.03x
Current ratio 4.39x
Net debt/EBITDA -2.45x
Stability
41 /100
Moderate Beta 0.46x
Rev. volatility 13.25%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PXMBF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Richard Paxman
Employees
144
Headquarters
Karlshamn
Upcoming events
20 NOV
Earnings
Upcoming earnings report